• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    AltruBio Shows ALTB-268 Efficacy in T Cell Inflammation at FOCIS

    GLOBENEWSWIRE

    AltruBio Announces Formation of Scientific Advisory Board

    GLOBENEWSWIRE

    AltruBio to Attend Jefferies & Piper Sandler Conferences

    GLOBENEWSWIRE

    AltruBio Presents ALTB-268 In Vivo Data at FIMSA 2024 Congress

    #N/A

    AltruBio Raises $225M Series B For Immune Checkpoint Program

    GLOBENEWSWIRE

    AltruBio Announces Enrollment of First Patient in Phase 2 Program of ALTB-268

    GLOBENEWSWIRE

    AltruBio Announces FDA Clearance of IND Application for ALTB-268

    GLOBENEWSWIRE

    AltruBio Announces Positive Topline Data from Phase 1 Trial of ALTB-268

    GLOBENEWSWIRE

    AltruBio Announces First Patient Dosed in Phase 1 Trial of Next-Generation Immune Checkpoint Enhancer ALTB-268 for the Treatment of Ulcerative Colitis

    GLOBENEWSWIRE

    AltruBio to Present at Biotech Showcaseâ„¢ 2023

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.